Company page

Agenus Inc.

Agenus Inc. is a public biotechnology company based in the United States, trading under the ticker AGEN. The company focuses on developing innovative immuno-oncology therapies to enhance cancer treatment. With a market capitalization of approximately $124.9 million, Agenus is actively engaged in advancing its pipeline of therapeutic candidates.